レチノイドX受容体を標的とした創薬に関する研究

DOI Web Site

書誌事項

タイトル別名
  • Discovery Research of Drugs Targeting Retinoid X Receptors
  • レチノイド X ジュヨウタイ オ ヒョウテキ ト シタ ソウヤク ニ カンスル ケンキュウ

この論文をさがす

抄録

So-called modern diseases such as type 2 diabetes, cancer, Alzheimer's disease and others are closely related to glucose and lipid metabolism. Therefore, improvement of the internal environment might be an effective therapeutic approach for these modern diseases. Since retinoid X receptors (RXRs), which are nuclear receptors that act as ligand-dependent transcription factors, function as homodimers or heterodimers with other nuclear receptors, a wide variety of biological effects and therapeutic effects on the above described diseases can be expected. However, the past RXR agonists cause serious side effects such as blood triglyceride elevation, hypothyroidism and others. Our research group has been advocating a strategy of "revival drug discovery" to revive abandoned drug targets based on the idea to avoid the side effects of drugs. In this review, our past discovery research of drugs targeting RXRs will be introduced.

収録刊行物

  • ビタミン

    ビタミン 90 (3), 101-108, 2016

    公益社団法人 日本ビタミン学会

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ